Sexually Transmitted Infections in Women Participating in a Biomedical Intervention Trial in Durban: Prevalence, Coinfections, and Risk Factors
Journal of Sexually Transmitted Diseases · 2013
DOI: 10.1155/2013/358402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Sexually Transmitted Diseases, 2013. Verfasst von Nathlee Samantha Abbai und 2 weiteren Autor:innen. Beteiligte Einrichtung: HIV Prevention Research Unit, Medical Research Council, Durban 4000, South Africa. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Medical Research Council, UK Department for International Development and the Medical Research Council, Australian Government Department of Health and Ageing.
Abstract (Originalsprache)
Background
Sexually transmitted infections (STIs) continue to be a significant public health problem especially among women of reproductive age in Africa.
Methods
A total of 2236 women that had enrolled in the MDP301 vaginal microbicide trial were tested for the presence of Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), Treponema pallidum, and Trichomonas vaginalis (TV).
Results
CT was identified as the most prevalent STI (11%) followed by TV (10%), NG, and Syphilis (3%). The highest prevalence of coinfection was reported between T. pallidum and TV (19.67%, P = 0.004 ), followed by CT and TV (13.52%, P ≤ 0.001 ). Risk factors that were significantly associated with STI acquisition were women of 23 years of age or younger (HR: 1.50, 95% CI 1.17, 1.93), baseline STI with CT (HR: 1.77, 95% CI 1.32, 2.35), TV (HR: 1.58, 95% CI, 1.20, 2.10), and T. pallidum (HR: 5.13, 95% CI 3.65, 7.22), and a low education level (HR: 1.30, 95% CI 1.02, 1.66).
Conclusion
Young women with lower education and a history of STIs are at high risk of multiple STIs. Prevention programs should consider target approach to STI prevention among young women. This trial is registered with ISRCTN64716212 .
Autor:innen und Institutionen
- HIV Prevention Research Unit, Medical Research Council, Durban 4000, South Africa.
- The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
- HIV Prevention Research Unit, Medical Research Council, Durban 4000, South Africa ; Department of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Förderung
- Medical Research Council
- UK Department for International Development and the Medical Research Council
- Australian Government Department of Health and Ageing
Zitieren
APA
Abbai, N. S., Wand, H., & Ramjee, G. (2013). Sexually Transmitted Infections in Women Participating in a Biomedical Intervention Trial in Durban: Prevalence, Coinfections, and Risk Factors. Journal of Sexually Transmitted Diseases. https://doi.org/10.1155/2013/358402
Vancouver
Abbai NS, Wand H, Ramjee G. Sexually Transmitted Infections in Women Participating in a Biomedical Intervention Trial in Durban: Prevalence, Coinfections, and Risk Factors. Journal of Sexually Transmitted Diseases. 2013. doi:10.1155/2013/358402
BibTeX
@article{Abbai2013,
author = {Abbai, Nathlee Samantha and Wand, Handan and Ramjee, Gita},
title = {Sexually Transmitted Infections in Women Participating in a Biomedical Intervention Trial in Durban: Prevalence, Coinfections, and Risk Factors},
journal = {Journal of Sexually Transmitted Diseases},
year = {2013},
doi = {10.1155/2013/358402}
}
EUVIMED